Rare diseases
Investigational molecules
Locations
Back to Spain71 clinical trials in Manises, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
SpainA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
SpainA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
SpainLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
SpainStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
SpainPhase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo
SpainLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
SpainStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
SpainA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
SpainA Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa
SpainA Study of LAD191 Compared to Placebo and Adalimumab in Adults with Moderate-to-Severe Hidradenitis Suppurativa
SpainStudy of sublingual immunotherapy with Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen mix for patients with dust mite allergic rhinitis
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on plaque psoriasis and atopic dermatitis, evaluating new therapeutic approaches for moderate to severe cases.
Multiple studies investigating novel compounds and treatment options for chronic skin conditions.
Comprehensive research into hidradenitis suppurativa, examining various therapeutic agents for managing this challenging condition.
Studies aim to improve quality of life for patients with chronic inflammatory conditions.
Research targeting specific conditions including prurigo nodularis, vitiligo, and chronic spontaneous urticaria.
Focused investigations on targeted treatments for specific dermatological conditions.
Studies examining treatments for heart failure and related conditions, with emphasis on combination therapies and patient outcomes.
Investigations into improving cardiovascular health through innovative treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
